We also analyzed the association between p53 expression and clinical factors in RCC, and the results suggested that p53 positive expression was closely related to higher tumor stage and grade, as well as distant metastases, which indicated that p53 had potential to be a dichotomous biomarker. The gene discussed is TP53; the disease is renal cell carcinoma.